Ecolab Inc. ECL SPX

Basic Materials · Specialty Chemicals · United States

https://www.ecolab.com

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

Market & Price

Market Cap

$72.05B

Current Price

$256.00

High / Low (52W)

$307.53 / $245.73

Beta

0.93

Valuation

Stock P/E

34.59

Industry PE

24.80

Forward P/E

26.65

PEG Ratio

2.36

Book Value

$35.55

Price to Book

7.20

P/S

4.38

EV/EBITDA

20.00

Dividend Yield

1.14%

Profitability & Returns

ROCE

14.89%

ROE

22.43%

ROA

8.01%

Profit Margin

12.80%

Op Margin

16.93%

EPS (Latest Qtr)

$1.52

EPS (TTM)

$7.40

Balance Sheet & Liquidity

Debt/Equity

0.92

Quick Ratio

0.68

Current Ratio

0.99

Debt

$9.27B

Total Assets

$24.70B

Current Assets

$5.96B

Working Capital

$420.90M

Ownership

Promoter Holding

0.15%

Chg in Prom Hold

FII / Inst Holding

93.53%

Chg in FII Hold

-0.00%

Financial Snapshot

Enterprise Value

$80.82B

Total Revenue (TTM)

$16.45B

EBITDA

$4.04B

Free Cash Flow

$1.59B

Operating Cash Flow

$3.03B

Shares Outstanding

281.44M

Gross Margin

44.37%

Payout Ratio

37.35%

Growth (CAGR)

Revenue 5Y

4.26%

Profit 5Y

23.88%

Revenue (YoY)

10.00%

Earnings (YoY)

7.80%

PROS

Strong return on equity of 22.4%.
Profit CAGR of 23.9% over 5 years.
Generates positive free cash flow.

CONS

In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Period: Metric:

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Basic Materials).

#	Name	CMP $	P/E	Mkt Cap	Div Yld %	ROCE %	ROE %	Rev CAGR 5Y %	Profit CAGR 5Y %
1	ECL Ecolab Inc. SPX	256.00	34.59	$72.05B	1.14%	14.89%	22.43%	4.26%	23.88%
2	LIN Linde plc NDXSPX	497.69	33.00	$230.11B	1.29%	13.07%	18.23%	0.62%	18.48%
3	NEM Newmont Corporation SPX	109.81	14.24	$117.23B	0.95%	22.51%	25.83%	23.91%	583.84%
4	FCX Freeport-McMoRan Inc. SPX	65.71	34.77	$94.46B	0.91%	12.93%	15.63%	4.39%	-14.02%
5	SHW The Sherwin-Williams Company SPX	303.84	29.16	$74.94B	1.05%	20.04%	60.72%	2.10%	8.34%
6	CRH CRH plc SPX	108.79	20.18	$72.69B	1.43%	11.33%	15.81%	4.60%	-1.15%
7	APD Air Products and Chemicals, Inc. SPX	278.62	29.33	$62.04B	2.60%	-0.62%	12.35%	-1.77%	-39.16%
8	NUE Nucor Corporation SPX	250.00	24.80	$56.94B	0.90%	8.80%	12.29%	-7.84%	-38.80%
9	CTVA Corteva, Inc. SPX	78.28	42.31	$52.36B	0.92%	6.08%	5.14%	-0.10%	-1.56%

Quarterly Results

Figures in USD.

Metric	Jun 2016	Sep 2016	Dec 2016	Mar 2017	Jun 2017	Sep 2017	Dec 2017	Mar 2018	Jun 2018	Sep 2018	Dec 2018	Mar 2019	Jun 2019	Sep 2019	Dec 2019	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Revenue	-	-	-	3.16B	3.46B	3.56B	3.65B	3.47B	3.69B	3.75B	3.76B	2.92B	3.17B	3.22B	3.24B	3.02B	2.69B	3.02B	3.07B	2.88B	3.16B	3.32B	3.36B	3.27B	3.58B	3.67B	3.67B	3.57B	3.85B	3.96B	3.94B	3.75B	3.99B	4.00B	4.01B	3.69B	4.03B	4.17B	4.20B	4.07B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.06B	2.22B	2.30B	2.35B	2.30B
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.63B	1.80B	1.87B	1.85B	1.77B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.05B	1.07B	1.08B	1.06B	1.10B
Operating Income	412.50M	574.10M	556.90M	357.20M	419.60M	564.10M	609.20M	354.30M	494.60M	516.20M	581.90M	313.60M	464.40M	549.00M	518.20M	376.20M	192.00M	411.40M	416.10M	297.30M	447.80M	465.80M	387.70M	254.50M	425.80M	483.00M	399.20M	351.60M	484.70M	566.00M	590.00M	517.90M	656.90M	1.04B	582.80M	584.80M	734.70M	786.40M	786.60M	668.40M
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	818.70M	977.80M	1.03B	999.30M	898.50M
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	72.60M	76.20M	74.60M	82.90M	77.30M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	510.00M	659.90M	717.70M	660.30M	558.10M
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	103.50M	131.40M	128.00M	91.70M	121.50M
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	193.60M	310.80M	324.50M	-	171.90M	308.30M	347.10M	-	233.40M	329.70M	404.00M	-	412.10M	490.90M	736.50M	-	402.50M	524.20M	585.00M	563.90M	432.60M
Diluted EPS	0.87	1.27	1.24	0.86	1.00	1.34	1.92	0.84	1.20	1.48	1.35	1.01	1.26	1.59	1.47	0.97	-6.98	0.85	1.04	0.67	1.08	1.12	1.04	0.60	1.08	1.21	0.93	0.82	1.15	1.41	1.41	1.43	1.71	2.58	1.66	1.41	1.84	2.05	1.98	1.52

Profit & Loss (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Revenue	-	-	-	-	-	-	-	-	-	13.15B	13.84B	12.22B	12.56B	11.79B	-	14.19B	15.32B	15.74B	16.08B
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	8.83B	9.15B	8.90B	8.93B
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.36B	6.17B	6.84B	7.15B
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3.65B	4.06B	4.23B	4.26B
Operating Income	669.00M	712.80M	681.30M	806.80M	753.80M	1.29B	1.56B	1.96B	1.56B	1.87B	1.95B	1.73B	1.85B	1.40B	-	1.70B	2.10B	2.61B	2.89B
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.53B	3.03B	3.85B	3.83B
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	252.10M	348.90M	340.30M	306.20M
Pretax Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.34B	1.76B	2.57B	2.55B
Tax Provision	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	234.50M	362.50M	439.30M	454.60M
Net Income	427.20M	448.10M	417.30M	530.30M	-	-	-	-	-	-	-	-	-	-	-	1.09B	1.37B	2.11B	2.08B
Diluted EPS	1.70	1.80	1.74	2.23	1.91	2.35	3.16	3.93	3.32	4.14	5.12	4.88	5.33	-4.15	-	3.81	4.79	7.37	7.28
R&D Expense	-	86.00M	86.00M	88.00M	96.00M	183.00M	188.00M	197.00M	191.00M	189.00M	201.00M	193.00M	190.00M	185.00M	186.00M	190.00M	192.00M	207.00M	202.00M

Compounded Sales Growth

5 Years:	4.26%
1 Year:	10.00%

Compounded Profit Growth

5 Years:	23.88%
1 Year:	7.80%

Stock Price Performance

1 Year:	-2.62%
6 Months:	-5.87%
3 Months:	-16.75%
1 Month:	-0.24%

Balance Sheet (Annual)

Figures in USD.

Metric	Dec 2006	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Assets	-	-	4.76B	5.02B	4.87B	18.18B	17.57B	19.64B	19.43B	18.64B	18.33B	19.96B	20.07B	20.87B	18.13B	-	21.46B	21.85B	22.39B	24.70B
Current Assets	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5.49B	5.64B	6.03B	5.96B
Cash & Equivalents	484.00M	137.40M	66.70M	73.60M	242.30M	1.84B	1.16B	339.20M	209.60M	92.80M	327.40M	211.40M	114.70M	118.80M	1.26B	-	598.60M	919.50M	1.26B	646.20M
Inventory	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.79B	1.50B	1.46B	1.49B
Receivables	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2.70B	2.83B	2.87B	3.25B
Total Liabilities	-	-	-	-	-	12.44B	11.41B	12.23B	12.05B	11.66B	11.36B	12.31B	12.02B	12.14B	11.92B	-	14.21B	13.77B	13.60B	14.89B
Current Liabilities	-	-	1.44B	1.25B	1.32B	3.17B	3.05B	3.49B	4.37B	4.76B	3.02B	3.48B	3.69B	3.63B	2.93B	-	4.21B	4.35B	4.79B	5.53B
Long Term Debt	-	-	799.30M	868.80M	656.40M	6.61B	-	-	-	-	-	-	-	-	-	-	8.08B	7.55B	6.95B	7.37B
Total Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.03B	8.73B	8.28B	9.00B
Total Equity	-	-	1.57B	2.00B	2.13B	5.67B	6.08B	7.34B	7.32B	6.91B	6.90B	7.58B	8.00B	8.69B	6.17B	-	7.24B	8.04B	8.76B	9.77B
Shares Outstanding	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	364.76M	365.75M	367.82M	369.42M

Cash Flows (Annual)

Figures in USD.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Operating Cash Flow	797.60M	753.20M	695.00M	950.40M	-	-	-	-	2.00B	1.94B	2.09B	2.28B	2.42B	1.86B	-	1.79B	2.41B	2.81B	2.95B
Investing Cash Flow	-663.70M	-580.70M	-299.30M	-303.60M	-	-	-	-	-915.80M	-773.60M	-1.73B	-1.03B	-1.20B	-414.50M	-	-716.80M	-990.50M	-433.80M	-2.71B
Financing Cash Flow	-482.40M	-235.60M	-397.80M	-462.20M	-	-	-	-	-1.15B	-868.20M	-522.70M	-1.17B	-1.35B	-341.80M	-	-837.30M	-1.05B	-2.02B	-853.30M
Capital Expenditure	-306.50M	-326.70M	-252.50M	-260.50M	-341.70M	-574.50M	-625.10M	-748.70M	-771.00M	-756.80M	-868.60M	-778.70M	-731.30M	-489.00M	-	-712.80M	-774.80M	-994.50M	-1.05B
Free Cash Flow	491.10M	426.50M	442.50M	689.90M	-	-	-	-	1.23B	1.18B	1.22B	1.50B	1.69B	1.37B	-	1.08B	1.64B	1.82B	1.90B
Net Change in Cash	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	234.30M	366.60M	356.00M	-607.90M
Share Buybacks	371.40M	337.20M	68.80M	348.80M	690.00M	209.90M	307.60M	428.60M	755.10M	739.60M	600.30M	562.40M	353.70M	146.20M	106.60M	518.20M	13.70M	986.50M	783.80M

Ratios (Annual)

Figures in %.

Metric	Dec 2007	Dec 2008	Dec 2009	Dec 2010	Dec 2011	Dec 2012	Dec 2013	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Gross Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	37.8%	40.2%	43.5%	44.5%
Operating Margin %	-	-	-	-	-	-	-	-	-	14.2%	14.1%	14.1%	14.7%	11.8%	-	12.0%	13.7%	16.6%	18.0%
Net Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7.7%	9.0%	13.4%	12.9%
ROE %	-	28.5%	20.9%	24.9%	-	-	-	-	-	-	-	-	-	-	-	15.1%	17.1%	24.1%	21.2%
ROCE %	-	21.5%	18.1%	22.7%	5.0%	8.9%	9.7%	13.0%	11.3%	12.2%	11.8%	10.5%	10.7%	9.2%	-	9.9%	12.0%	14.9%	15.1%

Shareholding Pattern

Insiders

0.15%

Institutions

93.53%

Public Float

93.68%

Top Institutional Holders

#	Holder	% Held	Shares	Value
1	Blackrock Inc.	8.10%	22.81M	$5.84B
2	Vanguard Capital Management LLC	5.87%	16.52M	$4.23B
3	JPMORGAN CHASE & CO	4.14%	11.66M	$2.99B
4	State Street Corporation	3.99%	11.22M	$2.87B
5	Morgan Stanley	2.77%	7.79M	$1.99B
6	Vanguard Portfolio Management LLC	2.25%	6.32M	$1.62B
7	Geode Capital Management, LLC	2.13%	5.99M	$1.53B
8	Gates Foundation Trust	1.85%	5.22M	$1.34B
9	Aristotle Capital Management, LLC	1.32%	3.71M	$949.37M
10	UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	1.27%	3.57M	$912.82M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for ECL

No recent headlines available.

ECL · Basic Materials

Ecolab Inc.

About

Key Facts

Sector	Basic Materials
Industry	Specialty Chemicals
Headquarters	United States
Employees	48,000
Website	https://www.ecolab.com

Press Esc or click outside to close.

Explore More

📊 Basic Materials Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks

Ecolab Inc. ECL SPX

Market & Price

Valuation

Profitability & Returns

Balance Sheet & Liquidity

Ownership

Financial Snapshot

Growth (CAGR)

PROS

CONS

Price Chart

Technical Trend

Fundamental Growth

Peer comparison

Quarterly Results

Profit & Loss (Annual)

Compounded Sales Growth

Compounded Profit Growth

Stock Price Performance

Balance Sheet (Annual)

Cash Flows (Annual)

Ratios (Annual)

Shareholding Pattern

Top Institutional Holders

Analyst View

Latest News

Explore More